A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders
Andrea J Gonzalez-Mantilla1, Andres Moreno-De-Luca2, David H Ledbetter3
1Autism & Developmental Medicine Institute, Geisinger Health System, Danville, Pennsylvania.
JAMA Psychiatry
|January 29, 2016
Summary
This study identified novel candidate genes for developmental brain disorders by integrating genomic and phenotypic data across multiple conditions. The findings highlight shared genetic causes and the complexity of these disorders.
Area of Science:
- Genetics
- Neuroscience
- Genomic Medicine
Background:
- Developmental brain disorders are genetically heterogeneous with high heritability.
- Advances in genome sequencing facilitate the identification of pathogenic variants.
- Shared genetic causes can underlie distinct phenotypic features.
Purpose of the Study:
- To identify novel candidate genes for developmental brain disorders.
- To provide evidence for previously implicated genes.
- To leverage a cross-disorder approach for enhanced gene discovery.
Main Methods:
- Searched PubMed for studies on developmental brain disorders (2003-2015).
- Employed a tiered, multilevel data-integration of whole-genome data (pathogenic loss-of-function variants) and phenotype data from six disorders.
- Prioritized genes based on inheritance patterns and the number of pathogenic loss-of-function variants in unrelated individuals.
Main Results:
- Reviewed 384 studies involving 1960 individuals with developmental brain disorders.
- Identified 241 genes with 2 or more pathogenic loss-of-function variants in at least two unrelated individuals.
- Discovered 7 novel high-confidence and 10 novel putative candidate genes, with 18 genes upgraded due to the cross-disorder approach.
Conclusions:
- The integrated, cross-disorder approach enhances gene discovery for developmental brain disorders.
- Results support shared genetic etiologies among seemingly distinct neurological conditions.
- The study underscores the significant clinical and genetic heterogeneity of developmental brain disorders.


